...
首页> 外文期刊>Research journal of pharmacy and technology >Development and Evaluation of Solid Dispersion Incorporated Topical Gel of Nabumetone
【24h】

Development and Evaluation of Solid Dispersion Incorporated Topical Gel of Nabumetone

机译:萘丁美酮固体分散体掺入局部凝胶的研制与评价

获取原文
获取原文并翻译 | 示例

摘要

The aim of present investigation was to increase dissolution rate of Nabumetone by solid dispersion technique and it is incorporated into the gel. All formulations were prepared by Kneading method and subsequently characterized and evaluated for drug release, interaction study by FT-IR, X-ray diffraction study, and DSC study from this study following points are concluded. A present study demonstrates the Kneading technique was successful for preparation of Nabumetone solid dispersion using PEG 4000, PEG 6000 and Poloxamer 188.The increased dissolution of Nabumetone with increase in the molar ratio of polymer. Amongst all batches of solid dispersion batch F9 showed Drug content 95.24±1.03 percentage drug release 92.53±0.7 within 1 Hour. FT-IR analysis suggest the intactness of the drag in the formulations. Results of XRD and DSC confirmed amorphous formation and their stabilization, preparation of solid dispersion of Nabumetone optimized and batch was incorporated into the gel. The prepared formulations were transparent opaque in appearance with .Carbopol 940.The drug content, pH, Extrudability and Spreadability was found within acceptable range.The viscosity of gel was increased as concentration of gelling agent increased/The optimum concentration of gelling agent for Carbopol 940 (0.8%w/w) was found to be good. Amongst all batches of Gel batch A2 showed Drug content 93.14±0.86 percentage drug release from diffusion study 95.68±0.59 within 1 Hour It is helpful for to improve the patient compliance toward the management of pain & inflammation topically and it overcome gastric side effect of drug.Stability study showed that the Gel formulation was stable and there is no significant change in physical properties and drug content.
机译:本研究的目的是通过固体分散技术提高萘丁美酮的溶解速率,并将其掺入凝胶中。根据以下几点,通过捏合法制备所有制剂,随后表征和评价药物释放,通过FT-IR的相互作用研究,X射线衍射研究和DSC研究。目前的研究表明,捏合技术成功地使用PEG 4000,PEG 6000和Poloxamer 188制备了萘丁美酮固体分散体。萘丁美酮的溶解度随聚合物摩尔比的增加而增加。在所有批次的固体分散体批次F9中,1小时内药物含量为95.24±1.03%,药物释放率为92.53±0.7。 FT-IR分析表明制剂中药物的完整性。 XRD和DSC的结果证实了无定形的形成及其稳定,优化了萘丁美酮的固体分散体的制备并将批料掺入凝胶中。制备的制剂在外观上是透明不透明的.Carbopol 940.药物含量,pH,可挤出性和可分散性均在可接受的范围内。凝胶的粘度随胶凝剂浓度的增加/胶凝剂的最佳浓度而增加(0.8%w / w)被认为是很好。在所有批次的Gel批次A2中,药物含量从扩散研究中释放的药物含量为93.14±0.86%,在1小时内为95.68±0.59,这有助于改善患者对局部疼痛和炎症的顺应性,并克服了药物的胃副反应稳定性研究表明,凝胶配方稳定,物理性质和药物含量没有明显变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号